Risk of thyroid cancer associated with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A population-based cohort study.
Sungho BeaHeejun SonJae Hyun BaeSun Wook ChoJu Young ShinYoung Min ChoPublished in: Diabetes, obesity & metabolism (2023)
GLP-1RAs and DPP-4 inhibitors were not associated with an increased risk of thyroid cancer in individuals with type 2 diabetes.
Keyphrases